Teen Girls and Boys Are Now Sacrificial Virgins: How the HPV Vaccine Has Destroyed Young Lives (Full Documentary)
Sacrificial Virgins is a 3 part documentary series written and narrated by Joan Shenton and directed by Andi Reiss, about the HPV vaccine.
The film alleges that the HPV vaccine, currently one of the most heavily pushed and popular vaccines, is also one of the worst offenders when it comes to adverse reactions, on a different scale of any other mass-administered vaccine.
Pictured above: Chloe Leanne Brookes became ill after her second injection, has suffered a form of paralysis and is now unable to eat and wholly dependent on intravenous fluids, medications and her mother’s care.
Sacrificial Virgins: Part I – Not for the greater good
The leading HPV vaccines Gardasil and Cervarix are widely administered, often freely in schools or through national immunization programs.
This, despite the fact that UK government records show that from 2008-2014, reports of adverse events attributed to the HPV vaccine far exceeded reports for any other vaccine, including those on the most common mass vaccination programmes.
In fact, by April 2017, there were almost 9,000 reports of adverse reactions, including more than 3,000 “serious” reports. No other vaccine comes close.
The number of studies that show that partial immunization via available HPV (human papillomavirus) vaccines is not only insufficient at reducing overall HPV infection rates; the vaccines actually cause rarer, more lethal types of HPV to sweep in and the net effect could be devastating increases in HPV-related cancers.
The first study is Center for Disease Control’s (CDC) own study, in which they show no net change in HPV infection rate (considering all types) after HPV vaccines were introduced into medical practice:
Markowitz LE et al., 2016 Prevalence of HPV After Introduction of the Vaccination Program in the United States. Pediatrics. 2016 Feb 22. pii: peds.2015-1968.
That study concluded that type replacement did not occur because their univariate analysis of individual types showed no individual type with a significant increase.
However, because the vaccines do clear the vaccine-targeted types, the lack of change in overall infection rate shows that type replacement must be occurring.
The second study is by Fisher et al. (2016), which specifically found that high-risk HPV types replaced the vaccine-targeted types. They wrote:
“the percentage of non-vaccine HR-HPV types was higher than expected, considering that eight HPV types formerly classified as ‘low-risk’ or ‘probably high-risk’ are in fact HR-HPV types.”
Fischer et al 2016: Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination. Oncol Lett. 12(1):601-610.
A third study is that by Guo et al., (2015) that also clearly found evidence of type replacement occurring as a result of HPV vaccination:
“The prevalence of high-risk nonvaccine types was higher among vaccinated women than unvaccinated women (52.1% vs 40.4%, prevalence ratio 1.29, 95% CI 1.06–1.57), but this difference was attenuated after adjusting for sexual behavior variables (adjusted prevalence ratio 1.19, 95% CI 0.99–1.43).
HPV vaccination was effective against all 4 vaccine types in young women vaccinated after age 12. However, vaccinated women had a higher prevalence of high-risk nonvaccine types, suggesting that they may benefit from newer vaccines covering additional types.”
Sacrificial Virgins: Part II – Pain and suffering
The HPV vaccine is a treatment in widespread use but its efficacy in preventing cancer is medically unproven, while unintended, adverse reactions are blighting and even ending the lives of girls and young women across the world.
However, pharmaceutical manufacturers and many health authorities are refusing to acknowledge there is a problem and the medical community is continuing to offer the vaccine.
Sacrificial Virgins: Part III – A penny for your pain